Last updated on November 2017

Type 2 Diabetes and treated with NPH or basal insulin


Brief description of study

Type 2 Diabetes and treated with NPH or basal insulin

Detailed Study Description

A 15 month clinical research study is evaluating if a new investigational basal insulin dosed once daily can provide safe and effective blood sugar control compared to a marketed basal insulin dosed once daily in people with type 2 diabetes.

Qualified participants will receive all study-related care and study medication at no cost and may be compensated for travel.

Clinical Study Identifier: TX81572

Contact Investigators or Research Sites near you

Start Over

Robert Rossi

Beacon Clinical Research
Quincy, MA USA

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.